News Oligomerix Announces Appointment of Robert Foerster, Former Pfizer Executive, as Chief Financial Officer May 8, 2020 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix Presents Preclinical Data at TAU2020 Global Conference for Small Molecule Inhibitor of Tau Self-AssociationNext →Oligomerix Appoints William Erhardt, M.D., as Chief Medical Officer
